Longevity
Humanin
Also called HN, HNG
per administration
Only animal or lab studies exist — no human study has set an amount.
Quick start
Humanin at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.
- Typical dose
- 5–10 mg per administration
- How often
- 3x per week
- Where
- Commonly subcutaneous Sites and rotation
- Time to steady level
- ~3 hours — about five half-lives
- Storage
- Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details
A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.
Work out your draw
These numbers are a starting point — change any of them.
Vial label
Copy this into your label printer.
Published research contexts for Humanin describe 5–10 mg per administration. Descriptive only, not a recommendation.
Mitochondrial-derived peptide; human pharmacokinetic data is thin.
A mitochondrial-derived peptide, with HNG a more stable analog; evidence is preclinical and circulating amounts are community-derived rather than trial-established, so no schedule table is shown.
Modelled level — 3x per week
1× is the peak after a single dose.
- Steady-state peak
- 1.00× single dose
- Time to steady state
- 3hours
- Administrations
- 3/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Humanin mitochondrial-derived peptide literatureLargely rodent and cell-model work on cytoprotection and metabolism; human dosing is not established.